Clinical

Quick Byte: PrEP advances


 

There are recent advances in preexposure prophylaxis, or PrEP, as a promising prevention option for HIV, according to a recent study.1

grandeduc/Thinkstock
“Modeling studies suggest that pre-exposure prophylaxis has the potential to curtail the HIV epidemic when used as part of a combination public health prevention strategy. The estimated number needed to treat to prevent one new infection might be as low as 13 when pre-exposure prophylaxis is given to a group at high risk of HIV (for example, incidence of 9%).”

Reference

1. Desai M, Field N, Grant R, McCormack S. “Recent advances in pre-exposure prophylaxis for HIV.” BMJ. 2017;359:j5011.

Recommended Reading

Antibiotic stewardship in sepsis
The Hospitalist
Severity of sepsis-associated coagulopathy predicts hospital mortality
The Hospitalist
Many hospitals had no mandatory flu vaccine requirements in 2017
The Hospitalist
Trio of blood biomarkers elevated in children with LRTIs
The Hospitalist
CDC concerned about multidrug-resistant Shigella
The Hospitalist
Hospital-acquired conditions drop 8% since 2014, saving 8,000 lives and $3 billion
The Hospitalist
CDC warns of hepatitis A outbreaks in injection drug users
The Hospitalist
CMS sepsis measure a challenge to report
The Hospitalist
Diagnosing pulmonary tuberculosis in the hospital
The Hospitalist
Biomarker duo rapidly identifies serious bacterial infections
The Hospitalist
   Comments ()